Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
JFrog to Present at Upcoming Investor Conference
-
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Inventiva Reports Preliminary 2024 First-Half Financial Information¹
-
Lion Electric (LEV) PT Lowered to $0.50 at Canaccord Genuity
-
ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS
-
MedAdvisor Solutions to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Perrigo to Attend the Canaccord Genuity 44th Annual Growth Conference
-
Alarum to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
-
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Olaplex Holdings, Inc. Announces Participation in the Canaccord Genuity 44th Annual Growth Conference on August 14th
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 30 07 2024] - (CGWL)
-
Lantronix Announces CEO and CFO Featured at Canaccord Genuity’s 44th Annual Growth Conference on Aug. 14, 2024
-
Vertex (VRTX) PT Raised to $376 at Canaccord Genuity
-
Penumbra (PEN) PT Lowered to $176 at Canaccord Genuity
-
Inari Medical Inc. (NARI) PT Raised to $71 at Canaccord Genuity
-
Corcept Therapeutics (CORT) PT Raised to $78 at Canaccord Genuity
-
Canaccord Genuity Upgrades Appen Ltd. (APX:AU) (APPEF) to Spec. Buy
-
Arrow Announces Second Ubaque Horizontal Well Results
-
The Beachbody Company, Inc. Announces Participation in Canaccord Genuity's 44th Annual Growth Conference
-
ASGN Incorporated Announces Participation in Canaccord Genuity 44th Annual Growth Conference
-
Tandem Diabetes Care Announces Upcoming Conference Presentation
-
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Delcath Systems to Participate in Upcoming Investor Conferences
-
Falcon’s Beyond to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
CMG to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference
-
Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
-
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
-
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
-
T2 Biosystems, Inc (TTOO) PT Raised to $5 at Canaccord Genuity
-
CVRx Inc (CVRX) PT Raised to $15 at Canaccord Genuity
-
Excellere Partners is Pleased to Announce That It Has Hired Two New Associates
-
Abaxx Announces Post Abaxx Exchange Launch Investor Events
-
AngioDynamics to Participate in Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
-
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
-
Akebia Therapeutics to Present at Upcoming Investor Conferences
-
Newell Rubbermaid (NWL) PT Raised to $12 at Canaccord Genuity
-
DocGo Announces Upcoming Participation at Canaccord Genuity 44th Annual Growth Conference
-
Vivid Seats to Participate in Canaccord Genuity’s 2024 Growth Conference
-
Lion One Announces Closing of Financings
-
Advantage Solutions Announces Date for its 2Q’24 Financial Results and Conference Call
-
DexCom (DXCM) PT Lowered to $89 at Canaccord Genuity
-
Loop Industries to Attend the Canaccord Genuity 44th Annual Growth Conference Taking Place August 13-15th, 2024
-
ICF to Present at the Canaccord Genuity 44th Annual Growth Conference
-
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Silver Elephant Closes 1st Tranche of Private Placement Raising Gross Proceeds of $1,111,584

